Up 103% from 52-week low, this largecap pharma stock is double upgraded by Jefferies to 'buy'
Zydus Lifesciences traded with gains after Jefferies double upgraded the counter.
Shares of Zydus Lifesciences will gain traction in Wednesday's trade (August 28) as global brokerage firm Jefferies double upgrades the largecap pharma stock. In the pre-opening session, the stock was up over 2 per cent at Rs 1,147.05 per share.
At the last count, at around 10:01 am, shares traded higher by around 2 per cent at Rs 1,132.55, while at the day's high it gained up to 4 per cent to Rs1,156.45. The stock's 52-week high and low prices are Rs 1,323.9 and Rs 567.85 per share, respectively.
What Jefferies make of Zydus Lifesciences stock?
Jefferies has double upgraded the stock to a 'buy' from the earlier 'hold' call and a raised target price of Rs 1,450 from the earlier target of Rs 1,210, implying substantial gains of over 30 per cent.
The global brokerage held that the current correction in the stock offers a good entry opportunity in the stock. The stock in 1-week has tumbled over 5 per cent, while in the last 1-month has fallen over 6 per cent.
The rationale for a buy is also given the company's strong product pipeline. The pharma leader intends to make $8- 10 crore launch every year.
Also, the brokerage expects the company's India market to record better sales and margins amid better growth opportunities. In view of all this, the brokerage expects the company to outperform the pharma space.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Senior Citizen Latest FD Rates: Know what major banks like SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on fixed deposits
Gratuity Calculator: Rs 38,000 as last-drawn basic salary, 5 years and 5 months of service; what will be gratuity amount?
Retirement Planning: In how many years your Rs 25K monthly SIP investment will grow to Rs 8.8 cr | See calculations
Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme
Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404
Top 7 Mid Cap Mutual Funds With up to 41% SIP Returns in 5 Years: No 1 fund has converted Rs 15,000 monthly investment into Rs 23,84,990
SBI 5-Year FD vs MIS: Which can offer higher returns on a Rs 2,00,000 investment over 5 years? See calculations
10:53 AM IST